Changli Lu

机构：Institute of Clinical Research, Clinical Science Institute

发表论文 54 篇 · 总被引 1111 次 · h-index 20

代表论文

• A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC (2020 · Hepatology International · 被引 122)
• Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway (2020 · Clinical Science · 被引 44)
• Brahma‐Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion (2021 · Hepatology · 被引 38)
• The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis (2018 · BMC Cancer · 被引 38)
• Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation (2018 · Canadian Journal of Gastroenterology and Hepatology · 被引 30)
• Congenital biliary atresia is correlated with disrupted cell junctions and polarity caused by Cdc42 insufficiency in the liver (2021 · Theranostics · 被引 24)